Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2012
08/15/2012EP2487186A1 Immunoregulatory structures from normally occuring proteins
08/15/2012EP2487155A1 Detection of Synthetic Cannabinoids
08/15/2012EP2486941A1 Human antibodies that bind CXCR4 and uses thereof
08/15/2012EP2486933A1 Monomethylvaline compounds conjugated with antibodies
08/15/2012EP2486141A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
08/15/2012EP2486060A1 Siglec 15 antibodies in treating bone loss-related disease
08/15/2012EP2486059A1 Monovalent ligands of the human cd28 receptor
08/15/2012EP2486058A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same
08/15/2012EP2486057A1 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer
08/15/2012EP2486056A1 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
08/15/2012EP2486055A2 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/15/2012EP2486054A2 Recombinant antibodies against h1n1 influenza
08/15/2012EP2486053A1 Rsv-specific binding molecule
08/15/2012EP2486052A2 Generation, characterization and uses thereof of anti-her 3 antibodies
08/15/2012EP2486046A1 A cytolytic rtx-toxin from gallibacterium anatis
08/15/2012EP2485763A2 Il-17 family cytokine compositions and uses
08/15/2012EP2485760A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
08/15/2012EP2485752A2 Enterotoxigenic e. coli fusion protein vaccines
08/15/2012EP2153843B1 Compositions and methods for the diagnosis and treatment of tumor
08/15/2012EP2076542B1 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for the treatment of certain cancers
08/15/2012EP1993596B1 Cancer vaccine
08/15/2012EP1889909B1 Improving disease resistance in plants by introducing transcription factor gene
08/15/2012EP1751181B1 BINDING MOIETIES BASED ON SHARK IgNAR DOMAINS
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN102639700A Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
08/15/2012CN102639699A DNA construct, and process for production of recombinant CHO cell using same
08/15/2012CN102639566A Bispecific binding molecules for anti-angiogenesis therapy
08/15/2012CN102639565A IL1RAP expression on acute and chronic myeloid leukemia cells
08/15/2012CN102639564A Anti-CMET antibody and its use for the detection and the diagnosis of cancer
08/15/2012CN102639563A Marker protein for type 2 diabetes
08/15/2012CN102639562A Human monoclonal antibody specific for lipopolysaccarides (LPS) of serotype IATS 01 of pseudomonas aeruginosa
08/15/2012CN102639561A Multivalent antibodies
08/15/2012CN102639557A Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
08/15/2012CN102639150A AX213 and AX132 PCSK9 antagonists and variants
08/15/2012CN102639147A RSV F protein compositions and methods for making same
08/15/2012CN102638971A Animal models and therapeutic molecules
08/15/2012CN102636644A Double-antibody sandwich ELISA (enzyme linked immunosorbent assay) kit used for detecting avian leukosis group specific antigen
08/15/2012CN102634524A Cell expansion lethal toxin and detection of bacterium belonging to campylobacter genus that targets the same
08/15/2012CN102634487A GPC3 (glypican-3) monoclonal antibody hybridoma strain 8G6, and preparation method and application thereof
08/15/2012CN102634486A GPC3 (glypican-3) monoclonal antibody hybridoma cell strain 7D11 and preparation method and application thereof
08/15/2012CN102633881A Antibodies directed to her-3 and uses thereof
08/15/2012CN102633880A Optimized fc variants and methods for their generation
08/15/2012CN102633879A Preparation and application of rabbit anti-human alpha-lactalbumin polyclonal antibody
08/15/2012CN102633878A H1-subtype influenza A virus double-antibody sandwich ELISA kit and application
08/15/2012CN102633876A Synthetic method and application of paraquat antigen
08/15/2012CN102633864A GPC3 antigen polypeptide, anti-GPC3 polyclonal antibody and application thereof
08/15/2012CN102226171B Diagnostic kit containing anti-dog hemoglobin monoclonal antibody and application thereof
08/15/2012CN101732333B Medicament for treating cancer
08/15/2012CN101684454B Method for preparing and separating definitive endoderm
08/15/2012CN101084233B Methods for reducing or eliminating alpha-mannosidase resistant glycans for the production of glycoproteins
08/15/2012CN101052877B Cytoxan antibodies and immunoassay
08/15/2012CN101037475B Chimerical receptor and preparation method and usage
08/14/2012USRE43586 Antibodies to prostate-specific membrane antigen
08/14/2012US8242250 Nucleic acid molecule encoding a cystine knot polypeptide
08/14/2012US8242248 Kits for multiparametric phospho analysis
08/14/2012US8242091 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1; peroxiredoxin
08/14/2012US8242074 Modulation of the amount or function of pathogenic CD14+CD16+ monocytes
08/14/2012US8241900 mpl ligand
08/14/2012US8241899 Anti-TNF antibodies, compositions, methods and uses
08/14/2012US8241897 Isolation of neural stem cells using gangliosides and other surface markers
08/14/2012US8241858 Rapid, sensitive and quantitative methods for tissue and cell-based proteomics via consecutive addition of quantifiable extenders
08/14/2012US8241856 Using filaggrin concentration in bodily fluids to diagnose arthritic disorders; immunoassay
08/14/2012US8241848 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/14/2012US8241639 Extracellular domains of Epstein Barr Virus (EBV) tumor-associated latent membrane proteins
08/14/2012US8241632 Stable polypeptide formulations
08/14/2012US8241628 Compositions and methods for antibodies targeting complement protein C5
08/14/2012US8241627 Modified polypeptides stabilized in a desired conformation and methods for producing same
08/14/2012US8241626 Serpentine transmembrane antigens expressed in human cancers and uses thereof
08/14/2012US8241625 Medicament and a method for regulation of the vascular tone
08/14/2012CA2522747C Method of detecting native probnp with a monoclonal antibody binding to the amino acids 38-43
08/14/2012CA2501821C Bispecific anti-erb-b antibodies and their use in tumor therapy
08/14/2012CA2486345C Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
08/14/2012CA2436326C Combination therapy using receptor tyrosine kinase inhibitors and angiogenesis inhibitors
08/14/2012CA2407905C Antibodies capable to selectively detect prion prpsc isoforms
08/14/2012CA2373274C Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
08/14/2012CA2283476C Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof
08/14/2012CA2218166C Methods of inducing immune tolerance using immunotoxins
08/09/2012WO2012106669A2 Foxc1 antibodies and methods of their use
08/09/2012WO2012106587A1 Fc VARIANTS AND METHODS FOR THEIR PRODUCTION
08/09/2012WO2012106578A1 HIV NEUTRALIZING ANTIBODIES HAVING MUTATIONS IN CONSTANT DOMAIN (Fc)
08/09/2012WO2012106192A1 Antibody specific for sulfatase-2 and methods of use thereof
08/09/2012WO2012105833A1 Antigen-binding protein directed against epitope in the ch1 domain of human igg antibodies
08/09/2012WO2012105699A1 Method for production of antibody having high complement-dependent biological activity
08/09/2012WO2012105541A1 Novel japanese cypress pollen allergen
08/09/2012WO2012104824A1 Therapeutic antibodies targeting app-c99
08/09/2012WO2012104647A1 Vaccine compositions
08/09/2012WO2012104581A1 Anti-tace antibody molecules and their uses
08/09/2012WO2012104344A1 Human antibodies and antibody-drug conjugates against cd74
08/09/2012WO2012104227A1 Novel antigen binding proteins
08/09/2012WO2012104014A1 A method for the production of hybridoma cell lines producing monoclonal antibodies capable to specifically binding to a human c44-fragment of agrin
08/09/2012WO2012103797A1 Antibody preparation method, and antibody and antibody library thus prepared
08/09/2012WO2012075342A3 Anti-bradykinin b2 receptor (bkb2r) monoclonal antibody
08/09/2012WO2012069433A3 Antigen binding proteins to oncostatin m (osm)
08/09/2012WO2012068073A3 Therapeutic and diagnostic applications targeting tnk-1
08/09/2012WO2012032525A3 An immunosuppressive drug combination for a stable and long term engraftment
08/09/2012WO2012016245A3 Fibronectin cradle molecules and libraries thereof
08/09/2012WO2012016073A3 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
08/09/2012WO2011088120A9 Antibody formulation and therapeutic regimens
08/09/2012WO2011083091A8 Methods for treating pancreatic cancer
1 ... 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 ... 1494